Abstract | BACKGROUND: METHODS: We retrospectively analyzed 49 women with cervical cancer aged >70 years primarily treated with radiotherapy (RT) or CCRT in our institute between 2003 and 2014. Treatment compliance, toxicity, and survival benefit were analyzed. RESULTS: A total of 49 patients were identified in this retrospective analysis. Twenty patients with a median age of 75.4 years (range 70-77) were treated with CCRT and 29 patients with a median age of 77.9 years (range 70-89) underwent RT. In the CCRT group, 14 patients (70%) completed CCRT consisting of radiotherapy and 5 courses of cisplatin plus 5-fluorouracil including patients requiring a dose reduction of chemotherapy. The median overall survival (OS) in the CCRT and RT groups was 66.9 and 60.1 months, respectively (p = 0.156). The most common grade 3/4 acute toxicity was hyponatremia (35.0%), followed by neutropenia (15.0%) and diarrhea (10.0%) in the CCRT group, while this was anemia (17.2%) followed by radiation enteritis (10.3%) in the RT group. CONCLUSIONS: CCRT was well tolerated in elderly patients with cervical cancer. Careful attention should be paid to the different characteristics of treatment-related toxicities in this group compared with younger patients.
|
Authors | Kazuto Nosaka, Kiyosumi Shibata, Fumi Utsumi, Kosuke Yoshida, Kaoru Niimi, Ryuichiro Sekiya, Shiro Suzuki, Hiroaki Kajiyama, Fumitaka Kikkawa |
Journal | Tumori
(Tumori)
Vol. 102
Issue 6
Pg. 600-605
(Dec 01 2016)
ISSN: 2038-2529 [Electronic] United States |
PMID | 27443893
(Publication Type: Journal Article)
|
Topics |
- Age Factors
- Aged
- Aged, 80 and over
- Chemoradiotherapy
(adverse effects, methods)
- Comorbidity
- Female
- Humans
- Kaplan-Meier Estimate
- Neoplasm Staging
- Patient Compliance
- Retrospective Studies
- Treatment Outcome
- Uterine Cervical Neoplasms
(diagnosis, mortality, therapy)
|